Effect of chronic AT1 receptor blockade on cardiac Smad overexpression in hereditary cardiomyopathic hamsters

Cardiovascular Research

Volumn 46, Issue 2, 2000, Pages 286-297

  Dixon, Ian M C ^a   Hao, Jianming ^a   Reid, Nicole L ^a   Roth, Julie C ^a  

^a ST BONIFACE GENERAL HOSPITAL RESEARCH CENTRE   (Canada)

Author keywords

Angiotensin; Cardiomyopathy; Fibrosis; Heart failure

Indexed keywords

ANGIOTENSIN 1 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HEART MUSCLE FIBROSIS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYRIAN HAMSTER;

ANALYSIS OF VARIANCE; ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CARDIOMYOPATHY, DILATED; COLLAGEN; CRICETINAE; DNA-BINDING PROTEINS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HYDROXYPROLINE; LOSARTAN; MALE; MATRIX METALLOPROTEINASES; MESOCRICETUS; MYOCARDIUM; RECEPTORS, ANGIOTENSIN; RNA, MESSENGER; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0034115116     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(00)00035-3     Document Type: Article

References (43)

1. Massie B.M., Shah N.B. Evolving trends in the epidemiologic factors of heart failure: rationale for preventive strategies and comprehensive disease management. Am Heart J. 133:1997;703-712.
2. Bajusz E. Hereditary cardiomyopathy: a new disease model. Am Heart J. 77:1969;686-696.
3. Dixon I.M.C., Ju H., Reid N.L., Scammell La Fleur T., Werner J.P., Jasmin G. Cardiac collagen remodeling in the cardiomyopathic Syrian hamster and the effect of losartan. J Mol Cell Cardiol. 29:1997;1837-1850.
4. Massague J. The transforming growth factor-beta family. Annu Rev Cell Biol. 6:1990;597-641.
5. Roberts A.B., Sporn M.B. The transforming growth factor-betas. Sporn M.B., Roberts A.B. Peptide growth factors and their receptors. vol. I:1990;420-472 Springer, New York.
6. Massague J. TGF-beta signal transduction. Annu Rev Biochem. 67:1998;753-791.
7. Engelmann G.L., Grutkoski P.S. Coordinate TGF-beta receptor gene expression during rat heart development. Cell Mol Biol Res. 40:1994;93-104.
8. Sun Y., Zhang J.Q., Zhang J., Ramires F.J. Angiotensin II transforming growth factor-beta1 and repair in the infarcted heart. J Mol Cell Cardiol. 30:1998;1559-1569.
9. Schieffer B., Wirger A., Meybrunn M., et al. Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin I.I. type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat. Circulation. 89:1994;2273-2282.
10. Smits J.F., van Krimpen C., Schoemaker R.G., Cleutjens J.P., Daemen M.J. Angiotensin II receptor blockade after myocardial infarction in rats: effects on hemodynamics, myocardial DNA synthesis, and interstitial collagen content. J Cardiovasc Pharmacol. 20:1992;772-778.
11. Macias Silva M., Abdollah S., Hoodless P.A., Pirone R., Attisano L., Wrana J.L. MADR2 is a substrate of the TGF-beta receptor and its phosphorylation is required for nuclear accumulation and signaling. Cell. 87:1996;1215-1224.
12. Wrana J.L., Attisano L., Wieser R., Ventura F., Massague J. Mechanism of activation of the TGF-beta receptor. Nature. 370:1994;341-347.
13. Massague J., Hata A., Liu F. TGF-beta signalling through the Smad pathway. Trends Cell Biol. 7:1997;187-192.
14. Lagna G., Hata A., Hemmati Brivanlou A., Massague J. Partnership between DPC4 and SMAD proteins in TGF-beta signalling pathways. Nature. 383:1996;832-836.
15. Zhang Y., Feng X., We R., Derynck R. Receptor-associated Mad homologues synergize as effectors of the TGF-beta response. Nature. 383:1996;168-172.
16. Chen X., Weisberg E., Fridmacher V., Watanabe M., Naco G., Whitman M. Smad4 and FAST-1 in the assembly of activin-responsive factor. Nature. 389:1997;85-89.
17. Liu F., Pouponnot C., Massague J. Dual role of the Smad4/DPC4 tumor suppressor in TGF-beta-inducible transcriptional complexes. Genes Dev. 11:1997;3157-3167.
18. Chiariello M., Ambrosio G., Cappelli Bigazzi M., Perrone Filardi P., Brigante F., Sifola C. A biochemical method for the quantitation of myocardial scarring after experimental coronary artery occlusion. J Mol Cell Cardiol. 18:1986;283-290.
19. Tyagi S.C., Matsubara L., Weber K.T. Direct extraction and estimation of collagenase(s) activity by zymography in microquantities of rat myocardium and uterus. Clin Biochem. 26:1993;191-198.
20. Smith P.K., Krohn R.I., Hermanson G.T., et al. Measurement of protein using bicinchoninic acid. Anal Biochem. 150:1985;76-85.
21. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:1987;156-159.
22. Ju H., Dixon I.M.C. Effect of angiotensin II on myocardial collagen gene expression. Mol Cell Biochem. 163-164:1996;231-237.
23. Ju H., Zhao S., Davinder S.J., Dixon I.M.C. Effect of AT1 receptor blockade on cardiac collagen remodeling after myocardial infarction. Cardiovasc Res. 35:1997;223-232.
24. qα and PLC-beta in scar and border tissue in heart failure due to myocardial infarction. Circulation. 97:1998;892-899.
25. Peterson D.J., Ju H., Hao J., Panagia M., Chapman D., Dixon I.M.C. Expression of Gia2 and Gsa in myofibroblasts localized to the infarct scar in heart failure due to myocardial infarction. Cardiovasc Res. 41:1999;575-585.
26. Di Nardo P., Minieri M., Carbone A., et al. Myocardial expression of atrial natriuretic factor gene in early stages of hamster cardiomyopathy. Mol Cell Biochem. 125:1993;179-192.
27. Di Nardo P., Fiaccavento R., Natali A., et al. Embryonic gene expression in nonoverloaded ventricles of hereditary hypertrophic cardiomyopathic hamsters. Lab Invest. 77:1997;489-502.
28. Ju H., Scammel La Fleur T., Dixon I.M.C. Altered mRNA abundance of calcium transport genes in cardiac myocytes induced by angiotensin II. J Mol Cell Cardiol. 28:1996;1119-1128.
29. Kawaguchi H., Shoki M., Sano H., et al. Phospholipid metabolism in cardiomyopathic hamster heart cells. Circ Res. 69:1991;1015-1021.
30. Gertz E.W. Cardiomyopathic Syrian hamster: a possible model of human disease. Prog Exp Tumor Res. 16:1972;242-260.
31. Bishop J.E., Greenbaum R., Gibson D.G., Yacoub M., Laurent G.J. Enhanced deposition of predominantly type I collagen in myocardial disease. J Mol Cell Cardiol. 22:1990;1157-1165.
32. Wunsch M., Sharma H.S., Markert T., et al. In situ localization of transforming growth factor beta 1 in porcine heart: enhanced expression after chronic coronary artery constriction. J Mol Cell Cardiol. 23:1991;1051-1062.
33. Weber K.T. Cardiac interstitium in health and disease: the fibrillar collagen network. J Am Coll Cardiol. 13:1989;1637-1652.
34. Hao J., Ju H., Zhao S., Junaid A., Scammell-La Fleur T., Dixon I.M. Elevation of expression of Smads 2, 3, and 4, decorin and TGF-beta in the chronic phase of myocardial infarct scar healing. J Mol Cell Cardiol. 31:1999;667-678.
35. Whitman M. Signal transduction. Feedback from inhibitory SMADs. Nature. 389:1997;549-551.
36. Besse S., Robert V., Assayag P., Delcayre C., Swynghedauw B. Nonsynchronous changes in myocardial collagen mRNA and protein during aging: effect of DOCA-salt hypertension. Am J Physiol. 267:1994;H2237-H2244.
37. Booz G.W., Baker K.M. Molecular signalling mechanisms controlling growth and function of cardiac fibroblasts. Cardiovasc Res. 30:1995;537-543.
38. Davison G., Hall C.S., Miller J.G., Scott M., Wickline S.A. Cellular mechanisms of captopril-induced matrix remodeling in Syrian hamster cardiomyopathy. Circulation. 90:1994;1334-1342.
39. Dollery C.M., McEwan J.R., Henney A.M. Matrix metalloproteinases and cardiovascular disease. Circ Res. 77:1995;863-868.
40. Spinale F.G., Coker M.L., Thomas C.V., Walker J.D., Mukherjee R., Hebbar L. Time-dependent changes in matrix metalloproteinase activity and expression during the progression of congestive heart failure: relation to ventricular and myocyte function. Circ Res. 82:1998;482-495.
41. Cohen-Gould L., Robinson T.F., Factor S.M. Intrinsic connective tissue abnormalities in the heart muscle of cardiomyopathic Syrian hamsters. Am J Pathol. 127:1987;327-334.
42. Dhalla N.S., Dixon I.M., Rupp H., Barwinsky J. Experimental congestive heart failure due to myocardial infarction: sarcolemmal receptors and cation transporters. Basic Res Cardiol. 86:(Suppl 3):1991;13-23.
43. Tyagi S.C., Kumar S., Voelker D.J., Reddy H.K., Janicki J.S., Curtis J.J. Differential gene expression of extracellular matrix components in dilated cardiomyopathy. J Cell Biochem. 63:1996;185-198.